Semi-parametric accelerated failure time regression analysis with application to interval-censored HIV/AIDS data

Statistics in Medicine

Volumn 25, Issue 22, 2006, Pages 3850-3863

  Xue, Hongqi ^a   Lam, K F ^b   Cowling, Benjamin J ^c   de Wolf, Frank ^d  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Asymptotically efficient; HIV; Interval censored data; Partial linear model; Sieve maximum likelihood estimator

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; DATA ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAXIMUM LIKELIHOOD METHOD; NONHUMAN; NONLINEAR SYSTEM; NONPARAMETRIC TEST; REGRESSION ANALYSIS; SIMULATION; STATISTICAL MODEL; VIRUS LOAD;

ANTI-RETROVIRAL AGENTS; COMPUTER SIMULATION; HIV; HIV INFECTIONS; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, BIOLOGICAL; NETHERLANDS; REGRESSION ANALYSIS; VIRAL LOAD;

EID: 33750878541     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2486     Document Type: Article

References (21)

1. Engle RF, Granger CWJ, Rice J, Weiss A. Semiparametric estimates of the relation between weather and electricity sales. Journal of the American Statistical Association 1986; 81:310-320.
2. Härdle W, Liang H, Gao J. Partially Linear Models. Physica-Verlag: Heidelberg, New York, 2000.
3. Huang J. Efficient estimation for the proportional hazards model with interval censoring. Annals of Statistics 1996; 24:540-568.
4. Huang J, Rossini AJ. Sieve estimation for the proportional-odds failure-time regression models with interval censoring. Journal of the American Statistical Association 1997; 92:960-967.
5. Shen X. Proportional odds regression and sieve maximum likelihood estimation. Biometrika 1998; 85:165-177.
6. Huang J, Wellner JA. Regression models with interval censoring. Proceedings of the Kolmogorov Seminar, Euler Mathematics Institute, St. Petersburg, Russia, 1993.
7. Li G, Zhang C. Linear regression with interval censored data. Annals of Statistics 1998; 26:1306-1328.
8. Shen X. Linear regression with current status data. Journal of the American Statistical Association 2000; 95:842-852.
9. Xue H, Lam KF, Li G. Sieve maximum likelihood estimator for semiparametric regression models with current status data. Journal of the American Statistical Association 2004; 99:346-356.
10. Fauci JS et al. for the Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. U.S. Department of Health and Human Services, Washington, D.C. http://aidsinfo.nih.gov/guidelines/ adult/AA.032304.pdf [10 June 2004].
11. Mocroft A, Gill MJ, Davidson W, Phillips AN. Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor. AIDS 1998; 12:2161-2167.
12. de Wolf F, Lange JMA, Bossuyt PMM et al. The ATHENA cohort study: implications of the introduction of HAART for the course of HIV-1 disease, public health and health care as well as the economic costs and benefits. Monitoring of Human Immunodeficiency Virus Type 1 (HIV-1) Infection in the Netherlands. HIV Monitoring Foundation: Amsterdam, 2001; 18-51.
13. Grenander U. Abstract Inference. Wiley: New York, 1981.
14. Shen X, Wong WH. Convergence rate of sieve estimates. Annals of Statistics 1994; 22:580-615.
15. Mocroft A, Vella S, Benfield TL et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA study group. Lancet 1998; 352:1725-1730.
16. van Sighem A, van de Wiel M, Ghani A et al. on behalf of the ATHENA cohort study group. Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS 2003; 17:2227-2236.
17. Mellors JW, Rinaldo Jr CR, Gupta P et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-1170.
18. O'Brien WA, Hartigan PM, Martin D et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. New England Journal of Medicine 1996; 334:426-431.
19. Powderly WG, Saag MS. Chapman S et al. Predictors of optimal virological response to potent antiretroviral therapy. AIDS 1999; 13:1873-1880.
20. Turnbull BW. The empirical distribution function with arbitrarily grouped, censored, and truncated data. Journal of the Royal Statistical Society, Series B 1976; 38:290-295.
21. Moore AL, Mocrofi A, Madge S et al. Gender differences in virologic response to treatment in an HIV-positive population: a cohort study. J AIDS 2001; 26:159-163.